|
|
|
 |
 |
 |
 |
MRC Biotech has patents in three exciting anti-cancer technologies: Vitamin D3; MRC202; and, MRC304.
Learn more about our development for each of these
drugs. |
 |
 |
|
 |
Welcome to MRC Biotech Pty Ltd, a privately held company operating from Sydney, Australia.
We are dedicated to developing new therapeutic options for cancer patients. Our technologies are focussed on the anti-cancer properties of existing drugs. Presently we have three technologies, still in the early stage of clinical development. As you explore our website you will find out more about how we intend to make a difference. |
|
|
